Product Information
NYSTATIN 100,000 UNIT/ML SUSP is a generic product labeled by PAI Holdings LLC, priced at $0.1401 per ML under NDC 00121086802. Its NADAC has been published 311 times since Sep 9, 2020.
FDA first approved this application on Jan 7, 2016. Its Orange Book therapeutic-equivalence code is AA.
Strength
100000 [USP'U]/mL
Manufacturer
PAI Holdings LLCNDC
00121086802
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
NYSTATINApproval Type
Generic (ANDA)
FDA Application
ANDA203621FDA Approved
1/7/2016
TE Code
AA
On Market Since
7/17/2020
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN 100,000 UNIT/ML SUSP has been published 311 times since Sep 9, 2020, and over the history we have for it it has declined 12.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1401 per ML |
|---|---|
| All-time high | $0.1741 (Nov 13, 2024) |
| All-time low | $0.0871 (Dec 21, 2022) |
| 52-week high | $0.1629 |
| 52-week low | $0.1401 |
| Median price | $0.1367 |
| Average price | $0.1320 |
| Largest weekly change | +34.7% (Mar 22, 2023) |
| Weeks tracked | 311 |
| Tracking since | Sep 9, 2020 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 60% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NYSTATIN 100,000 UNIT/ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN 100,000 UNIT/ML SUSP, manufactured by PAI Holdings LLC, is $0.1401 per ML (NDC 00121086802), effective Aug 19, 2026.
How has the price of NYSTATIN 100,000 UNIT/ML SUSP changed over time?
Over the history we have for it, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has declined 12.7%. It has been tracked across 311 weekly CMS publications since Sep 9, 2020.
What are the highest and lowest recorded NADAC prices for NYSTATIN 100,000 UNIT/ML SUSP?
Since Sep 9, 2020, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has ranged from a low of $0.0871 (Dec 21, 2022) to a high of $0.1741 (Nov 13, 2024), with a median of $0.1367 per ML.
Are there cheaper alternatives to NYSTATIN 100,000 UNIT/ML SUSP?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN 100,000 UNIT/ML SUSP, is $0.0561 per ML — about 60% below NYSTATIN 100,000 UNIT/ML SUSP.
Who manufactures NYSTATIN 100,000 UNIT/ML SUSP?
NYSTATIN 100,000 UNIT/ML SUSP (NDC 00121086802) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.